Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent

Accardo, Antonella; Salsano, Giuseppina; Morisco, Anna; Aurilio, Michela; Parisi, Antonio; Maione, Francesco; Cicala, Carla; Tesauro, Diego; Aloj, Luigi; De Rosa, Giuseppe; Morelli, Giancarlo
January 2012
International Journal of Nanomedicine;2012, Vol. 7, p2007
Academic Journal
No abstract available.


Related Articles

  • Folate Receptor Targeted Gene Delivery Using Cationic Liposomes as Nonviral Vectors. Gorle, S.; Ariatti, Mario; Singh, M. // International Proceedings of Chemical, Biological & Environmenta;2013, Vol. 52, p1 

    Gene therapy is a promising strategy for the treatment of human diseases rooted in genetic disorders such as cancer. The success of gene therapy however depends on the efficient delivery of therapeutic genes into target cells in vitro and in vivo. Liposomes have shown the potential to be ligand-...

  • Tumor specific liposomes improve detection of pancreatic adenocarcinoma in vivo using optoacoustic tomography. Wenyuan Yin; Kimbrough, Charles W.; Gomez-Gutierrez, Jorge G.; Burns, Christopher T.; Chuong, Phillip; Grizzle, William E.; McNally, Lacey R. // Journal of Nanobiotechnology;12/1/2015, Vol. 13, p1 

    Background: Pancreatic cancer often goes undiagnosed until late stage disease due in part to suboptimal early detection. Our goal was to develop a Syndecan-1 tagged liposome containing fluorescent dye as an improved contrast agent for detection of pancreatic adenocarcinoma in vivo using...

  • Synthesis of bombesin-functionalized iron oxide nanoparticles and their specific uptake in prostate cancer cells. Martin, Amanda L.; Hickey, Jennifer L.; Ablack, Amber L.; Lewis, John D.; Luyt, Leonard G.; Gillies, Elizabeth R. // Journal of Nanoparticle Research;Jun2010, Vol. 12 Issue 5, p1599 

    The imaging of molecular markers associated with disease offers the possibility for earlier detection and improved treatment monitoring. Receptors for gastrin-releasing peptide are overexpressed on prostate cancer cells offering a promising imaging target, and analogs of bombesin, an amphibian...

  • Bombesin Analogue-Mediated Delivery Preferentially Enhances the Cytotoxicity of a Mitochondria-Disrupting Peptide in Tumor Cells. Yang, Hao; Cai, Huawei; Wan, Lin; Liu, Shan; Li, Shengfu; Cheng, Jingqiu; Lu, Xiaofeng // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Tumor-homing peptides that recognize specific markers on tumor cells have shown potential as drug carriers for targeted cancer therapy. Bombesin receptors are frequently overexpressed or ectopically expressed in a wide range of human tumors. Bombesin and its analogues have been widely used as...

  • A novel assay for monitoring internalization of nanocarrier coupled antibodies. Nielsen, Ulrik B; Kirpotin, Dmitri B; Pickering, Edward M; Drummond, Daryl C; Marks, James D // BMC Immunology;2006, Vol. 7, p24 

    Background: Discovery of tumor-selective antibodies or antibody fragments is a promising approach for delivering therapeutic agents to antigen over-expressing cancers. Therefore it is important to develop methods for the identification of target- and function specific antibodies for effective...

  • Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA. Waser, Beatrice; Eltschinger, Véronique; Linder, Karen; Nunn, Adrian; Reubi, Jean Claude // European Journal of Nuclear Medicine & Molecular Imaging;Jan2007, Vol. 34 Issue 1, p95 

    To investigate the in vitro binding properties of a novel radiolabelled bombesin analogue, 177Lu-AMBA, in human neoplastic and non-neoplastic tissues selected for their expression of the bombesin receptor subtypes GRP-R, NMB-R and BRS-3. In vitro receptor autoradiography was performed in cancers...

  • DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours. Zhang, Hanwen; Schuhmacher, Jochen; Waser, Beatrice; Wild, Damian; Eisenhut, Michael; Reubi, Jean Claude; Maecke, Helmut R. // European Journal of Nuclear Medicine & Molecular Imaging;Aug2007, Vol. 34 Issue 8, p1198 

    We aimed at designing and developing a novel bombesin analogue, DOTA-PEG4-BN(7–14) (DOTA-PESIN), with the goal of labelling it with 67/68Ga and 177Lu for diagnosis and radionuclide therapy of prostate and other human cancers overexpressing bombesin receptors. The 8-amino acid peptide...

  • EGFR Targeted Theranostic Nanoemulsion for Image-Guided Ovarian Cancer Therapy. Ganta, Srinivas; Singh, Amit; Kulkarni, Praveen; Keeler, Amanda; Piroyan, Aleksandr; Sawant, Rupa; Patel, Niravkumar; Davis, Barbara; Ferris, Craig; O'Neal, Sara; Zamboni, William; Amiji, Mansoor; Coleman, Timothy // Pharmaceutical Research;Aug2015, Vol. 32 Issue 8, p2753 

    Purpose: Platinum-based therapies are the first line treatments for most types of cancer including ovarian cancer. However, their use is associated with dose-limiting toxicities and resistance. We report initial translational studies of a theranostic nanoemulsion loaded with a cisplatin...

  • Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancer. Yu, Zilin; Carlucci, Giuseppe; Ananias, Hildo; Dierckx, Rudi; Liu, Shuang; Helfrich, Wijnand; Wang, Fan; de Jong, Igle; Elsinga, Philip // Amino Acids;Feb2013, Vol. 44 Issue 2, p543 

    Multimerization of peptides can improve the binding characteristics of the tracer by increasing local ligand concentration and decreasing dissociation kinetics. In this study, a new bombesin homodimer was developed based on an ε-aminocaproic acid-bombesin(7-14) (Aca-bombesin(7-14)) fragment,...

  • Ligand-Targeted Liposomes for Cancer Treatment. Sapra, Puja; Tyagi, Pradeep; Allen, Theresa M. // Current Drug Delivery;Dec2005, Vol. 2 Issue 4, p369 

    Selective targeting of ligand-targeted liposomes containing anticancer drugs or therapeutic genes to cell surface receptors expressed on cancer cells is a recognized strategy for improving the therapeutic effectiveness of conventional chemotherapeutics or gene therapeutics. Some recent advances...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics